Michael Schweizer, MD
Michael Schweizer, MD, decided to work in health care because he wanted to feel intellectually challenged in his career and, more importantly, he wanted to do something that would allow him to help people. Medicine was the perfect fit. “Early on in my training, I realized that you often see the best in people when they are faced with a cancer diagnosis,” Dr. Schweizer said. “The hope that my patients have in spite of being diagnosed with such serious illnesses is inspiring. It’s my patients’ hope that motivates me and makes me want to be a part of working toward cures.” Dr. Schweizer’s research involves translational genitourinary cancer. “My goal is to help reduce the morbidity and mortality associated with diseases like prostate cancer through developing novel drug therapies. Cancer is a formidable foe, but one that I believe we can vanquish. I hope to be a part of bringing the dream of a world without cancer into reality. I hope to see cancer cured in my lifetime.” Outside of work, Dr. Schweizer enjoys cooking, hiking, and spending time with his wife and two children.
We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
SCCA providers are often asked to give their medical expertise for press and news publications. Read articles by or about this SCCA provider.
SCCA's Michael Schweizer, MD, spoke with OncLive about data from three metastatic prostate cancer clinical trials.
SCCA's Michael Schweizer, MD, discussed the results of the HERO trial in prostate cancer.
Your care team
SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.